Sort
82,697 grants matching “vaccine development”
TASK A88: Ferret Model for Testing of Universal Influenza Vaccine Candidates
$986,910David Kelvin · University Health Network · N01 · FY2015 · AI
Mesothelin-targeted immunotoxins in Pancreatic Cancer
$986,847Christine Alewine · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Immune Senescence
$986,831Jorg J Goronzy · Emory University · U19 · FY2017 · AI
Maternal Immunity
$986,751Marcela F Pasetti · University Of Maryland Baltimore · U19 · FY2023 · AI
Mucosal Immunopathogenesis of Franscisella Tularensis
$986,732Albany Medical College · P01 · FY2003 · AI
Preclinical Evaluation of a Novel Immunomodulatory Vaccine for Preventing and Treating HSV Infections
$986,717Edward Gershburg · Rational Vaccines, Inc. · R44 · FY2025 · AI
A Universal Flu Vaccine Based On Conformationally Locked Soluble Headless HA
$986,704Mark Yondola · Calder Biosciences, Inc. · R44 · FY2018 · AG
Screening for rAAV transduction enhancers
$986,692Terry L Bowlin · Microbiotix, Inc · R44 · FY2022 · AI
NIAID Centers of Excellence for Influenza Research and Response
$986,678Scott Hensley · University Of Pennsylvania · N01 · FY2024 · AI
Targeting HIV reservoirs in children with HIVIS DNA and MVA-CMDR vaccines
$986,671Merlin L Robb · Henry M. Jackson Fdn For The Adv Mil/Med · U01 · FY2021 · AI
Advanced Development of Vaccines for Filoviruses
$986,612John Eldridge · Auro Vaccines Llc · N01 · FY2021 · AI
Multi-level Optimization of the Cervical Cancer Screening Process in Diverse Settings & Populations (METRICS)
$986,593Amy E Hughes · Ut Southwestern Medical Center · UM1 · FY2023 · CA
A human cytomegalovirus-based immunotherapy for HIV-1
$986,519Eric Bruening · Tomegavax, Inc. · R44 · FY2015 · AI
Molecular mechanisms of antibody-mediated immunotherapies
$986,490Jeffrey Victor Ravetch · Rockefeller University · R35 · FY2019 · CA
Coronavirus genomics and bioinformatics analysis
$986,465Xiaofang Jiang · National Library Of Medicine · ZIA · FY2021 · LM
Administrative Core and Data Management Center
$986,431Henry M Blumberg · Emory University · U19 · FY2018 · AI
Emory/Georgia TB Research Advancement Center (TRAC)
$986,410Neel Rajnikant Gandhi · Emory University · P30 · FY2022 · AI
NIAID Preclinical Development Support - Production of Research Cell Lines
$986,406Thomas Vancott · Advanced Bioscience Laboratories, Inc. · N02 · FY2014 · AI
PROGRESS: PRevention of cervical cancer using the Genotyping scREening and Same-day Self-sampling
$986,359Youxiang Wang · Atila Biosystems, Inc. · R44 · FY2023 · CA
Understanding Co-morbidities: COVID-19 in individuals living with HIV/AIDS
$986,355Dhiraj Kumar Singh · Texas Biomedical Research Institute · R01 · FY2024 · AI
Universal Attenuated Malaria Sporozoite Vaccine and Challenge System
$986,281Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2010 · AI
Chicago Community-Acquired Pneumonia Consortium
$986,255Richard G Wunderink · Northwestern University At Chicago · U18 · FY2009 · IP
Prophylactic Immunotherapy for Marburg Virus Disease Outbreak Control
$986,248M. Javad Aman · Abvacc, Inc. · R44 · FY2023 · AI
A human cytomegalovirus-based immunotherapy for HIV-1
$986,188Eric Bruening · Tomegavax, Inc. · R44 · FY2016 · AI
A Randomized Phase I Clinical Trial of HydroVax-CHIKV, a Novel Inactivated Chikungunya Virus Vaccine
$986,133Ian James Amanna · Najit Technologies, Inc. · U44 · FY2024 · AI